Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Blocking the KATP channel may help treat migraines.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Propranolol, flunarizine, and divalproex sodium are equally effective for preventing migraines, but have different side effects.

People with early psychosis eat more calories, saturated fat, and sugar, and the drug olanzapine may lead to eating even more calories.

rTMS may help treat trichotillomania in some patients.

Consider THPP in patients with muscle weakness and low potassium, as it is often underdiagnosed.

Sodium valproate is effective in treating epilepsy, especially in patients who don't respond to other medications.

Progesterone and its metabolites can prevent seizures without major side effects.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A teenager's hair loss was caused by the drug quetiapine but improved after stopping the medication.

Some antiseizure medications can cause cosmetic problems like hair loss, excessive hair growth, acne, and gum overgrowth.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Convulsofin effectively treats primary epilepsy but has some side effects.

Early diagnosis and treatment of TPP can prevent complications.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.